NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)
NIH offers access to biospecimens from brain development and tobacco and health studies for research on genetic and environmental factors affecting lifelong health and disease.
Funder: National Institutes of Health
Due Dates: April 15, 2027 (Application) | September 15, 2027 (Application) | April 17, 2028 (Application) | September 15, 2028 (Application) | April 17, 2029 (Application)
Funding Amounts: No funds awarded; biospecimen access for projects lasting up to 5 years
Summary: Access ABCD, HBCD, and PATH Study biospecimens to investigate genetic and environmental influences on health and disease.
Key Information: Applicants pay research and sample-distribution costs; proof of adequate funding is required before samples are released.
Description
This NIH X01 Resource Access Program provides access to limited biospecimens from the Adolescent Brain Cognitive Development (ABCD) Study, HEALthy Brain and Child Development (HBCD) Study, and Population Assessment of Tobacco and Health (PATH) Study. Projects must align with the respective study’s objectives and maximize the scientific utility of its samples. The program seeks to expand understanding of genetic and environmental factors, including substance exposures, affecting health and disease across the lifespan.
NBDC priorities include genomics and epigenetics, substance exposure, inflammation and stress, proteomics, neurotoxicants and environmental exposures, microbiome, and nutriture. Broader child and adolescent health studies are also considered, excluding exploratory or pilot studies. PATH prioritizes tobacco regulatory science while also considering studies of tobacco use and tobacco-related health outcomes.
